Related Experiment Video
Updated: Jul 10, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Effectiveness of Enhanced Recovery After Surgery Protocols for Robot Assisted Radical Prostatectomy: A Systematic
Joshua Bruinsma1,2, Nicholas A Clausen3, Rostyslav Nikolenko3
1Department of Urology, Royal Perth Hospital, Perth, Australia.
Summary
Enhanced recovery after surgery (ERAS) protocols significantly improve gastrointestinal function after robotic-assisted radical prostatectomy (RARP). While ERAS shortens hospital stays, its impact on length of stay (LOS) may be modest with modern surgical techniques.
Area of Science:
- Urology
- Surgical Oncology
- Perioperative Medicine
Background:
- Enhanced Recovery After Surgery (ERAS) protocols are evidence-based pathways to optimize surgical outcomes.
- ERAS is established for radical cystectomy but less defined for robotic-assisted radical prostatectomy (RARP).
- This study systematically reviews ERAS in RARP to assess its safety and efficacy.
Purpose of the Study:
- To evaluate the impact of ERAS protocols on perioperative outcomes in patients undergoing RARP.
- To compare ERAS protocols against standard care in RARP patients.
- To analyze the effects of ERAS on length of stay, bowel function, and complication rates.
Main Methods:
- Systematic literature search of PubMed, EMBASE, and Cochrane Central Register (PRISMA guidelines).
- Inclusion of studies comparing ERAS/modified ERAS with standard care in RARP patients.
- Random-effects meta-analysis of outcomes including LOS, bowel function, operative time, blood loss, and complications.
Main Results:
- Seven studies (1314 patients) were included; ERAS significantly reduced length of stay (LOS).
- ERAS protocols demonstrated earlier return of bowel function (flatus and defecation).
- No significant differences were found in complication rates, operative time, or blood loss between ERAS and standard care.
Conclusions:
- ERAS protocols enhance short-term postoperative recovery, particularly gastrointestinal function, in RARP patients.
- The clinical benefit of ERAS on LOS may be modest in current practice due to early discharge trends.
- Future research should identify key ERAS components and their value in higher-risk patient groups.